🇺🇸 FDA
Patent

US 6861415

21-substituted progesterone derivatives as new antiprogestational agents

expired A61PA61P15/00A61P15/04

Quick answer

US patent 6861415 (21-substituted progesterone derivatives as new antiprogestational agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61P, A61P15/00, A61P15/04, A61P15/08, A61P5/24